![CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings | Business Wire CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings | Business Wire](https://mms.businesswire.com/media/20210505005619/en/876282/22/Logo.jpg)
CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings | Business Wire
![Innovative Humanized Research Strategies for Immuno-Oncology Drug Development Crown Bioscience Hosts a Live Webinar - Pharma Advancement Innovative Humanized Research Strategies for Immuno-Oncology Drug Development Crown Bioscience Hosts a Live Webinar - Pharma Advancement](https://www.pharmaadvancement.com/wp-content/uploads/pa-images/Crown_Bio-11545.jpg)
Innovative Humanized Research Strategies for Immuno-Oncology Drug Development Crown Bioscience Hosts a Live Webinar - Pharma Advancement
Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanese Customers
Crown Bioscience Inc. - Don't miss our presentation today at the PBSS Symposium from Dr Dean Campbell, discussing tumor organoids for oncology drug discovery and CAR-T cell therapy development https://bit.ly/2L824Hy | فيسبوك
![Crown Bioscience Publishes New Study in PLOS ONE Highlighting the Use of Clinically Relevant 3D In Vitro PDX-Derived Organoid Models as Powerful Tools to Accelerate Cancer Drug Discovery | Business Wire Crown Bioscience Publishes New Study in PLOS ONE Highlighting the Use of Clinically Relevant 3D In Vitro PDX-Derived Organoid Models as Powerful Tools to Accelerate Cancer Drug Discovery | Business Wire](https://mms.businesswire.com/media/20230105005843/en/1678386/5/RajendraKumari-QuoteCard.jpg)